Imaging the Urokinase Plasminongen Activator Receptor in Preclinical Breast Cancer Models of Acquired Drug Resistance

Subtype-targeted therapies can have a dramatic impact on improving the quality and quantity of life for women suffering from breast cancer. Despite an initial therapeutic response, cancer recurrence and acquired drug-resistance are commonplace. Non-invasive imaging probes that identify drug-resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: LeBeau, Aaron M., Sevillano, Natalia, King, Mandy L., Duriseti, Sai, Murphy, Stephanie T., Craik, Charles S., Murphy, Laura L., VanBrocklin, Henry F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915090/
https://www.ncbi.nlm.nih.gov/pubmed/24505235
http://dx.doi.org/10.7150/thno.7323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915090/
https://www.ncbi.nlm.nih.gov/pubmed/24505235
http://dx.doi.org/10.7150/thno.7323

Ejemplares similares